Page 17 - Service Testing News Today

By Nina Kienle MorphoSys shares fell after the company raised 102.7 million euros ($111.7 million) in a capital increase to accelerate the launch of a...

Moderna's stock was on track for its biggest one-day gain in more than a year.

Vertex disclosed promising test results for a drug that could offer an alternative to opioids.

By Adria Calatayud Novartis's investigational drug iptacopan achieved its primary goal in a late-stage clinical trial for treatment of kidney disease C3...

By Sabela Ojea Shares of Anixa Biosciences climbed 14% to $4.47 in after-hours trading after the company presented positive results regarding its Phase 1...

Altimmune shares have jumped this week as analysts see potential for the company to find a partner for its promising experimental weight-loss drug.

Health-care companies fell as traders rotated into sectors with more to gain from a shift in Federal Reserve policy. Drug giant Merck & Co. pulled the...

By Helena Smolak Shares of Germany's Merck KGaA plunged after its experimental drug evobrutinib failed in two late-stage trials of patients with relapsing...

By Mauro Orru Roche Holding said its investigational treatment, inavolisib, showed promise in a late-stage study to treat patients with breast cancer. The...

By Dean Seal A clinical trial of Replimune Group's RP1 as a treatment for cutaneous squamous cell carcinoma failed to meet its primary endpoints. The...